April 23, 2018 / 4:52 AM / 5 months ago

BRIEF-Relief Therapeutics Grants Option To License Aviptadil To Seren Clinical

1 Min Read

April 23 (Reuters) - RELIEF THERAPEUTICS Holding SA:

* ANNOUNCES THAT IT HAS GRANTED AN OPTION TO LICENSE AVIPTADIL TO SEREN CLINICAL

* PRE-NEGOTIATED FINANCIAL TERMS OF PUTATIVE FUTURE LICENSING AGREEMENT NOT DISCLOSED Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below